Literature DB >> 28089809

Sensitivity and Specificity of Intraoperative Neuromonitoring for Identifying Safety and Duration of Temporary Aneurysm Clipping Based on Vascular Territory, a Multimodal Strategy.

Brittany Staarmann1, Kelly O'Neal2, Mark Magner1, Mario Zuccarello3.   

Abstract

BACKGROUND: Patients who undergo clipping of cerebral aneurysms face an inherent risk for new postoperative neurologic deficits. Intraoperative neuromonitoring (IONM) is used often for early detection of ischemic changes, while it is still potentially reversible. However, the value, safety, and efficacy of temporary clipping and multimodal IONM to minimize risks are debated. Our retrospective series examined the sensitivity and specificity of IONM using transcranial motor evoked potentials and somatosensory evoked potentials and quantified the safety of temporary clipping by duration and vascular territory.
METHODS: Our prospectively collected database (2010-2013) included 123 consecutive patients who underwent clipping of 133 cerebral aneurysms with use of IONM. We determined postoperative deficit rate and sensitivity and specificity of monitoring to predict these changes intraoperatively. The rate of permanent deficit after temporary clipping was correlated with duration, vascular territory, and IONM findings.
RESULTS: Of 133 clipped aneurysms, 15 instances of IONM changes occurred, including 12 temporary without new postoperative deficit and 3 permanent with new postoperative deficit. Somatosensory evoked potential monitoring predicted one of the permanent deficits and transcranial motor evoked potentials predicted the other 2 deficits.
CONCLUSIONS: Multimodal IONM was highly specific and sensitive for detecting new deficits. Three patients with new deficits had temporary clipping, including 2 patients with IONM changes not temporally associated with clip placement. Our 1.1% rate of permanent neurologic deficit attributed to temporary clipping support its safety. Differences in patterns of IONM changes among vascular territories warrant further investigation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral aneurysms; Intraoperative monitoring; Postoperative deficits; Somatosensory evoked potentials; Transcranial motor evoked potentials

Mesh:

Year:  2017        PMID: 28089809     DOI: 10.1016/j.wneu.2017.01.009

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Neurophysiological monitoring during neurosurgery: anesthetic considerations based on outcome evidence.

Authors:  Benjamin F Gruenbaum; Shaun E Gruenbaum
Journal:  Curr Opin Anaesthesiol       Date:  2019-10       Impact factor: 2.706

2.  Efficacy of evoked potential monitoring for predicting postoperative motor status in internal carotid artery aneurysm surgeries.

Authors:  Hao You; Xing Fan; Dongze Guo; Zhibao Li; Xiaorong Tao; Lei Qi; Miao Ling; Jiajia Liu; Hui Qiao
Journal:  J Clin Monit Comput       Date:  2021-03-23       Impact factor: 1.977

3.  Precise MEP monitoring with a reduced interval is safe and useful for detecting permissive duration for temporary clipping.

Authors:  Masahiro Kameda; Tomohito Hishikawa; Masafumi Hiramatsu; Takao Yasuhara; Kazuhiko Kurozumi; Isao Date
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

4.  Usefulness of Intraoperative Neurophysiological Monitoring During the Clipping of Unruptured Intracranial Aneurysm: Diagnostic Efficacy and Detailed Protocol.

Authors:  Dougho Park; Byung Hee Kim; Sang-Eok Lee; Eunhwan Jeong; Kwansang Cho; Ji Kang Park; Yeon-Ju Choi; Suntak Jin; Daeyoung Hong; Mun-Chul Kim
Journal:  Front Surg       Date:  2021-02-26

5.  Improved potential quality of intraoperative transcranial motor-evoked potentials by navigated electrode placement compared to the conventional ten-twenty system.

Authors:  Arthur Wagner; Sebastian Ille; Caspar Liesenhoff; Kaywan Aftahy; Bernhard Meyer; Sandro M Krieg
Journal:  Neurosurg Rev       Date:  2021-05-27       Impact factor: 2.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.